Scientists zap brains to unravel Pain's secrets
NCT ID NCT06968689
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looks at how gentle electrical brain stimulation changes the way the brain processes pain. Researchers will use EEG and fMRI to measure brain activity in 60 healthy adults while they experience pressure pain. The goal is to better understand the brain circuits involved in pain, which could one day lead to new pain relief methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- transcranial alternating current stimulation (tACS) and transcranial random noise stimulation (tRNS)
- What this could lead to
- If successful, this could reveal how brain rhythms influence pain, potentially guiding future non-invasive pain treatments.
- What could go wrong
- This is an early-phase, small study (60 participants) focused on understanding pain mechanisms, not testing a treatment. Results may not lead to direct therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of Texas Health Science Center at Houston
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- Electric pulses on the wrist may tame colonoscopy pain
- Virtual reality may distract patients from pain and fear during anesthesia
- Could a gentle yoga practice turn down the Body's pain and inflammation?
- Can a 5-Pill opioid prescription match a 30-Pill one after hip surgery?
- Parkinson's pain: could a new Add-On drug bring relief?